Hospital outpatient pharmacy leaders cite staffing shortages, managing multiple vendors, and navigating insurer red tape—specialty drug referrals and prior authorization requirements, specifically—among top workplace challenges, a new survey finds. As 340B providers continue to grapple with pharmaceutical manufacturer contract pharmacy
…
Congress’ attitude toward the 340B program will likely change in 2023 and 2024 because of November’s midterm election results, 340B Report Publisher and CEO Ted Slafsky predicts in his latest column for Omnicell.
It is customary for the party that
…
SPONSORED CONTENT
For decades, the 340B drug pricing program has served an important purpose by helping hospitals and other covered entities receive discounted prices on drugs to offset care provided to vulnerable, underserved populations.
But over the past several years, drug companies have started pushing back on the 340B program by putting restrictions and conditions in place that have threatened to dismantle it altogether. These restrictions are causing significant financial losses for covered entities with contract pharmacy relationships.
One such condition has been for covered entities to submit their 340B contract pharmacy claims data to drug companies through a third-party contractor called ESP. The goal was to provide a secure and easy-to-use platform for 340B covered entities (CEs) and pharmaceutical manufacturers to work together to resolve duplicate discounts. Ideally, the CEs submit their claims data, ESP takes the data and submits it to the manufacturer, and pricing is restored to the covered entity. This has also given CEs the
…
It’s not just the drug industry stepping up its effort to influence the public and policymakers over the increasingly heated battle over the 340B program.
Groups that represent 340B hospitals and hospital pharmacists have launched a digital advertising campaign “to
…
The clerk of the U.S. Supreme Court on Monday formally notified the clerk of a federal appeals court in Washington, D.C., and lawyers for three hospital groups and three health systems of the high court’s June 15 judgement in the
…
SPONSORED CONTENT
In Democracy in America, French sociologist and political theorist Alexis de Tocqueville spoke of the importance of advocacy to American civil society: “In the United States, as soon as several inhabitants have taken an opinion or an idea they wish to promote in society, they seek each other out and unite together once they have made contact. From that moment, they are no longer isolated but have become a power seen from afar whose activities serve as an example and whose words are heeded.”
As the 340B drug pricing program faces unprecedented attacks at multiple levels, effective advocacy as envisioned by de Tocqueville is critical to preserve and protect this essential program. All stakeholders who depend on the savings of 340B to improve access to healthcare need to speak with a loud and unified voice, and 340B covered entities have an obligation to advocate at the national and state level to ensure the program continues to
…
U.S. Senate Democrats are hopeful that drug pricing legislation will be passed by early next month via a budget reconciliation process requiring just 50 Democratic votes, a Democratic source with knowledge of the process told 340B Report.
“Our expectation is, we’re
…
Pharmaceutical Research and Manufacturers of America ran a full-page advertisement in the A section of The Washington Post this morning blasting 340B hospitals and drug store chains. According to a PhRMA spokesperson, it is part of a new ad campaign
…
Groups that represent 340B hospitals praised the Biden administration’s decision Friday to end a deep cut in the hospitals’ Medicare Part B drug reimbursement in place since 2018. They urged the government to swiftly make 340B hospitals whole for their
…*Sign up for news summaries and alerts from 340B Report
